Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Ganglioneuroblastoma × dinutuximab × Clear all

Phase

Status

Recruiting 2 Active not recruiting 2 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 2 Ganglioneuroblastoma 1

Interventions

Magnetic Resonance Spectroscopy 2 sargramostim 1 iberdomide 1 dinutuximab 1 Topotecan 1 Specimen Handling 1 Cyclophosphamide 1 Colony-Stimulating Factors 1 Biopsy 1 3-fluorobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07437963 2026-03-19

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

National Cancer Institute (NCI)

Phase 1/2 Not yet recruiting

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡